Can early removal of a ureteral stent—before the standard 1–2 weeks after ureteroscopy or 2–4 weeks after percutaneous nephrolithotomy—lead to kidney trauma or functional loss?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Early Ureteral Stent Removal After Kidney Stone Surgery: Risk of Kidney Trauma

Premature removal of a ureteral stent after kidney stone surgery can lead to serious complications including ureteral obstruction, urinoma formation, infection, and potential kidney damage—particularly when removed before adequate healing has occurred following ureteral injury or manipulation. 1, 2

Critical Timing Considerations

The standard duration for ureteral stent placement varies by procedure and complexity:

  • After uncomplicated ureteroscopy: Routine stenting may not be necessary at all in select cases, but when placed, stents are typically maintained for at least 3–7 days 3, 4
  • After ureteral injury or trauma: Stents should remain in place significantly longer to allow proper healing 1
  • After percutaneous nephrolithotomy (PCNL): Extended stenting of 2–4 weeks is often required 2
  • With residual stone burden, solitary kidney, or renal insufficiency: Stents must not be removed prematurely, as temporary stenting is required to maintain drainage and protect renal function 2

Specific Risks of Premature Stent Removal

Ureteral Obstruction and Urinoma Formation

When a stent is removed too early after ureteral manipulation or injury, the ureter may not have healed sufficiently, leading to:

  • Ureteral stricture or collapse causing acute obstruction 1
  • Urinoma formation from persistent urine leak through incompletely healed ureteral defects 1
  • Progressive hydronephrosis that can develop or worsen after premature stent removal 5

The AUA guidelines specifically recommend urinary drainage (via stent replacement or percutaneous nephrostomy) when complications such as enlarging urinoma, fever, increasing pain, or fistula develop 1. These complications are more likely when stents are removed before adequate healing.

Infection and Sepsis Risk

Early stent removal in the setting of incomplete healing or residual stone burden creates conditions for:

  • Obstructive pyelonephritis if any degree of ureteral narrowing develops 6
  • Pyonephrosis requiring emergent drainage, with survival rates of only 60% with medical therapy alone versus 92% with proper drainage 6
  • Urosepsis from infected obstructed systems 2, 6

Functional Kidney Loss

The most severe consequence of premature stent removal is potential kidney damage:

  • Deep renal lacerations (AAST Grade IV-V) are prone to developing complications such as urinoma or hemorrhage, requiring follow-up imaging after 48 hours 1
  • Ureteral injuries managed with stenting require adequate time for healing; premature removal can lead to complete ureteral obstruction and progressive renal damage 1
  • Warm ischemia from prolonged obstruction beyond 60 minutes leads to significant exponential losses in kidney function 1

Evidence on Stent Duration

Research comparing different stent durations demonstrates:

  • 3-day versus 7-day stenting: Patients with 3-day stents were significantly more likely to experience post-procedure events within 3 days of stent removal (23% vs 3%, p=0.026), with worse outcomes regarding flank pain 7
  • Late complications: One study found that 32.7% of ureteral stents had to be removed due to late complications, but premature removal creates different risks related to inadequate healing 5

Clinical Algorithm for Stent Management

Indications That Mandate Extended Stenting (Do Not Remove Early):

  1. Ureteral injury or perforation during the procedure 1, 3
  2. Significant residual stone burden requiring staged procedures 2
  3. Solitary kidney or baseline renal insufficiency 2
  4. Ureteral stricture or anatomic abnormality 1
  5. Active infection or UTI at time of procedure 3
  6. Pregnancy 3
  7. Significant intraoperative bleeding or trauma 3

Signs of Complications After Premature Stent Removal:

Monitor for these red flags that indicate the stent was removed too early:

  • Persistent or worsening flank pain beyond 48-72 hours 1, 2
  • Fever, leukocytosis, or signs of infection 1, 6
  • Gross hematuria lasting >48-72 hours 2
  • Worsening renal function (rising creatinine) 6
  • Abdominal distention or ileus 1

Immediate Management if Stent Removed Too Early:

If complications develop after premature stent removal:

  1. Obtain contrast-enhanced CT urogram to assess for hydronephrosis, urinoma, perinephric stranding, or abscess 2, 6
  2. Urgent stent replacement or percutaneous nephrostomy if obstruction, enlarging urinoma, or infection is present 1, 2
  3. Broad-spectrum IV antibiotics (ceftriaxone 1-2g daily) if infection is suspected 6
  4. Do not delay drainage while awaiting imaging if patient is septic or hemodynamically unstable 6

Critical Pitfalls to Avoid

  • Never remove a stent early in patients with documented ureteral injury, as this can lead to complete obstruction and kidney loss 1
  • Do not rely on absence of symptoms to determine readiness for stent removal; objective healing time is required 1
  • Avoid premature removal in solitary kidneys where any complication could result in dialysis dependence 2
  • Ensure adequate follow-up is arranged before stent removal, as complications may develop days after removal 7, 5

The European Urology guidelines specifically recommend against routine stenting after uncomplicated procedures but emphasize that stenting is mandatory in cases with trauma, residual fragments, bleeding, perforation, UTI, or pregnancy 3. This underscores that when these conditions exist, the stent must remain in place for adequate duration—premature removal in these scenarios significantly increases morbidity risk.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Ureteral Obstruction

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Ureteral Access Sheath Complications and Prevention Strategies

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Late complications of ureteral stents.

European urology, 2000

Guideline

Management of Obstructive Pyelonephritis with Sepsis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the best course of action for an elderly patient with a ureteral stent (indwelling ureteric catheter) in place for an infected kidney stone who continues to experience fevers (pyrexia)?
Can an adult patient with no significant medical history drive a tricycle one week after undergoing laser lithotripsy with a ureteral stent?
What are the common causes of flank pain occurring shortly after ureteral stent removal?
Do ureter (urinary tube) stents need to be removed?
What is the next best step in managing a patient with persistent hydronephrosis and impaired renal function due to ureteral obstruction?
What is the first‑line pharmacologic treatment for an adult with attention‑deficit/hyperactivity disorder (ADHD) who has no contraindications such as uncontrolled hypertension, significant cardiac disease, severe substance‑use disorder, or pregnancy?
Which artery is most likely occluded causing mottling of the right chin and nose?
How should I diagnose a heart block?
How should I manage hypotension in a patient with triple‑vessel disease, left‑ventricular failure, diabetes mellitus, hypertension, and ischemic heart disease who is already on norepinephrine?
What neoadjuvant therapy regimen is recommended for a patient with locally advanced, resectable gastric cancer (clinical stage T2‑T4a, N+), including dosing and alternative options?
Now that the target weight has been reached, can a 165 cm, 75 kg patient be maintained on semaglutide (Wegovy) 0.5–1.0 mg weekly instead of the approved 2.4 mg weekly dose?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.